![Photo](/media/story/21415/thumbnail-01-pancreatic-cancer-cells-nationalcancerinstitute.jpg)
News • Against rebound
Pancreatic cancer: Genome-wide analysis reveals new strategies
For some cancers, initial treatment with chemotherapy brings positive, but only temporary, results: tumors shrink, but then rebound as the cancer becomes drug-resistant. This pattern of remission-resistance-relapse is particularly true for pancreatic cancer, an aggressive disease in which early success is often countered by eventual disease progression. To wit: The one-year relative survival rate…